Prolongation of the Life Span of Cardiomyopath : Hamster by the Adrenergic β1-Selective Partial Agonist Denopamine

Influence of cardiotonic agents on the prognosis of heart failure depends on the individual therapeutic agents, and favorable and unfavorable effects of these agents have been reported in clinical trials. We studied the effect of the cardiotonic agent denopamine on the life span of cardiomyopathic h...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of pharmacology 1996, Vol.72 (4), p.325-333
Main Authors: Kurosawa, Hideo, Narita, Hiroshi, Kaburaki, Minako, Yabana, Hideo, Doi, Hisayoshi, Itogawa, Emiko, Okamoto, Masahito
Format: Article
Language:English
Subjects:
Cardiomyopathic hamster
Congestive heart failure
Denopamine
Plasma catecholamine level
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Influence of cardiotonic agents on the prognosis of heart failure depends on the individual therapeutic agents, and favorable and unfavorable effects of these agents have been reported in clinical trials. We studied the effect of the cardiotonic agent denopamine on the life span of cardiomyopathic hamsters (BIO 14.6 strain) in the heart failure period. Non-treated hamsters started to die at 40 weeks of age, and their survival rate decreased to 23.8% at the age of 65 weeks. Hamsters treated with denopamine (400 ppm in diet) from 36 weeks of age did not die until the age of 52 weeks, except in cases of accidental death. The survival rate of this group at 65 weeks of age was about 40%. Survival rates of these 2 groups were significantly different (P
ISSN:0021-5198
1347-3506
DOI:10.1254/jjp.72.325